A twenty-first century research agenda for polycystic ovary syndrome

Richard S. Legro, Ricardo Azziz, Linda Giudice

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Notwithstanding the significant progress made in our understanding of polycystic ovary syndrome (PCOS), the field remains ripe for further discovery and more intensive translational research. Immediate priorities include developing evidence-based criteria for diagnosing PCOS and for assessing the response to the various treatments available. The basis for the identification of PCOS remains mainly expert opinion, and the lack of universally accepted evidence-based criteria limits the generalizability of research studies on PCOS. Additional important areas requiring intensive investigation include the natural history and etiology and the long-term sequelae and prevention of the disorder. Overall, this disorder is a prototype for the benefits of translational science and a transdisciplinary approach to understanding the pathophysiology and therapy for anovulatory infertility.

Original languageEnglish (US)
Pages (from-to)331-336
Number of pages6
JournalBest Practice and Research: Clinical Endocrinology and Metabolism
Volume20
Issue number2
DOIs
StatePublished - Jun 1 2006

Fingerprint

Polycystic Ovary Syndrome
Research
Translational Medical Research
Expert Testimony
Natural History
Infertility
Therapeutics

Keywords

  • diagnosis
  • evidence-based
  • polycystic ovary syndrome
  • research
  • treatment

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

A twenty-first century research agenda for polycystic ovary syndrome. / Legro, Richard S.; Azziz, Ricardo; Giudice, Linda.

In: Best Practice and Research: Clinical Endocrinology and Metabolism, Vol. 20, No. 2, 01.06.2006, p. 331-336.

Research output: Contribution to journalReview article

Legro, Richard S. ; Azziz, Ricardo ; Giudice, Linda. / A twenty-first century research agenda for polycystic ovary syndrome. In: Best Practice and Research: Clinical Endocrinology and Metabolism. 2006 ; Vol. 20, No. 2. pp. 331-336.
@article{67cd0cede10d4ffeab601d6b01d2e8c5,
title = "A twenty-first century research agenda for polycystic ovary syndrome",
abstract = "Notwithstanding the significant progress made in our understanding of polycystic ovary syndrome (PCOS), the field remains ripe for further discovery and more intensive translational research. Immediate priorities include developing evidence-based criteria for diagnosing PCOS and for assessing the response to the various treatments available. The basis for the identification of PCOS remains mainly expert opinion, and the lack of universally accepted evidence-based criteria limits the generalizability of research studies on PCOS. Additional important areas requiring intensive investigation include the natural history and etiology and the long-term sequelae and prevention of the disorder. Overall, this disorder is a prototype for the benefits of translational science and a transdisciplinary approach to understanding the pathophysiology and therapy for anovulatory infertility.",
keywords = "diagnosis, evidence-based, polycystic ovary syndrome, research, treatment",
author = "Legro, {Richard S.} and Ricardo Azziz and Linda Giudice",
year = "2006",
month = "6",
day = "1",
doi = "10.1016/j.beem.2006.03.001",
language = "English (US)",
volume = "20",
pages = "331--336",
journal = "Best Practice and Research in Clinical Endocrinology and Metabolism",
issn = "1521-690X",
publisher = "Bailliere Tindall Ltd",
number = "2",

}

TY - JOUR

T1 - A twenty-first century research agenda for polycystic ovary syndrome

AU - Legro, Richard S.

AU - Azziz, Ricardo

AU - Giudice, Linda

PY - 2006/6/1

Y1 - 2006/6/1

N2 - Notwithstanding the significant progress made in our understanding of polycystic ovary syndrome (PCOS), the field remains ripe for further discovery and more intensive translational research. Immediate priorities include developing evidence-based criteria for diagnosing PCOS and for assessing the response to the various treatments available. The basis for the identification of PCOS remains mainly expert opinion, and the lack of universally accepted evidence-based criteria limits the generalizability of research studies on PCOS. Additional important areas requiring intensive investigation include the natural history and etiology and the long-term sequelae and prevention of the disorder. Overall, this disorder is a prototype for the benefits of translational science and a transdisciplinary approach to understanding the pathophysiology and therapy for anovulatory infertility.

AB - Notwithstanding the significant progress made in our understanding of polycystic ovary syndrome (PCOS), the field remains ripe for further discovery and more intensive translational research. Immediate priorities include developing evidence-based criteria for diagnosing PCOS and for assessing the response to the various treatments available. The basis for the identification of PCOS remains mainly expert opinion, and the lack of universally accepted evidence-based criteria limits the generalizability of research studies on PCOS. Additional important areas requiring intensive investigation include the natural history and etiology and the long-term sequelae and prevention of the disorder. Overall, this disorder is a prototype for the benefits of translational science and a transdisciplinary approach to understanding the pathophysiology and therapy for anovulatory infertility.

KW - diagnosis

KW - evidence-based

KW - polycystic ovary syndrome

KW - research

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=33744941083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744941083&partnerID=8YFLogxK

U2 - 10.1016/j.beem.2006.03.001

DO - 10.1016/j.beem.2006.03.001

M3 - Review article

C2 - 16772161

AN - SCOPUS:33744941083

VL - 20

SP - 331

EP - 336

JO - Best Practice and Research in Clinical Endocrinology and Metabolism

JF - Best Practice and Research in Clinical Endocrinology and Metabolism

SN - 1521-690X

IS - 2

ER -